While the average growth rate of global pharmaceutical market is about 4-5%, China's pharmaceutical market has been growing at a rate of around 30% during the last few years. However, China's pharmaceutical market is complex, with over 5,000 domestic drug companies and the world top 20 pharmaceutical companies competing for the multi-billion market.
Compared with other developed markets where patented drugs capture over half of the market, pharmaceutical market in China is dominant by domestic companies that produce generics with a 63% market share; patented drugs from multinational pharmaceutical companies represent about 15% share. OTC drugs capture about 22% market share. The growth rate of generic drugs is significant at around 28-30% compared with 20-23% of patented products from multinational pharmaceutical companies.
Trial Application
Pre-order
2012
无数据
201201
Pharmaceuticals China Bimonthly Report 1201
Published Date:1 Jan 2012
Table of Contents
Editor's Notes
Published Date:
25 Dec 2025
Editor's Notes 201201
Please purchase to view
Regulatory & Policies
Published Date:
24 Dec 2025
MOH announces progress on public hospitals expenditures control
NDRC updates essential drugs tendering system and healthcare reform
SFDA ensures essential drugs safety and supply
SFDA strengthens control on internet drug selling
Please purchase to view
Market & Industry Dynamics
Published Date:
24 Dec 2025
Major therapeutic classes market review
Antibiotic control impact
SFDA requested recall of Caelyx and Velcade
Chinese pharmaceuticals received FDA approval
Please purchase to view
Business & Companies Dynamics
Published Date:
24 Dec 2025
BMS and Simcere expand strategic cooperation
Simcere launches Iremod for active rheumatoid arthritis